Trupanion (NASDAQ:TRUP – Get Rating) was upgraded by equities researchers at Bank of America from a “neutral” rating to a “buy” rating in a research note issued on Thursday, The Fly reports. The analysts noted that the move was a valuation call.
A number of other research firms have also weighed in on TRUP. Canaccord Genuity Group reduced their price objective on Trupanion from $150.00 to $140.00 in a research note on Thursday, February 17th. Piper Sandler reduced their price objective on Trupanion from $183.00 to $156.00 in a research note on Monday, February 7th. StockNews.com upgraded Trupanion to a “sell” rating in a research note on Monday. Finally, Lake Street Capital reduced their price objective on Trupanion from $150.00 to $120.00 in a research note on Thursday, February 17th. One research analyst has rated the stock with a sell rating, one has given a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $129.00.
Shares of TRUP opened at $74.07 on Thursday. The stock has a 50-day moving average of $104.02 and a two-hundred day moving average of $103.67. Trupanion has a one year low of $69.74 and a one year high of $158.25. The stock has a market cap of $3.00 billion, a P/E ratio of -92.59 and a beta of 1.95.
Trupanion (NASDAQ:TRUP – Get Rating) last issued its quarterly earnings results on Wednesday, February 16th. The financial services provider reported ($0.17) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.15) by ($0.02). Trupanion had a negative return on equity of 8.69% and a negative net margin of 4.94%. The firm had revenue of $194.38 million for the quarter, compared to analyst estimates of $193.09 million. During the same period in the prior year, the firm posted ($0.09) EPS. The business’s revenue was up 36.2% compared to the same quarter last year. As a group, equities research analysts predict that Trupanion will post -0.87 EPS for the current fiscal year.
In related news, insider Margaret Tooth sold 350 shares of Trupanion stock in a transaction dated Tuesday, December 28th. The stock was sold at an average price of $137.00, for a total value of $47,950.00. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Darryl Rawlings sold 4,000 shares of Trupanion stock in a transaction dated Monday, November 29th. The stock was sold at an average price of $123.85, for a total value of $495,400.00. The disclosure for this sale can be found here. In the last 90 days, insiders sold 53,022 shares of company stock valued at $6,317,481. 6.77% of the stock is owned by company insiders.
Hedge funds have recently bought and sold shares of the stock. FNY Investment Advisers LLC acquired a new stake in Trupanion in the 4th quarter worth about $28,000. Rational Advisors LLC boosted its holdings in Trupanion by 112.5% in the 4th quarter. Rational Advisors LLC now owns 238 shares of the financial services provider’s stock worth $31,000 after buying an additional 126 shares during the last quarter. Lindbrook Capital LLC acquired a new stake in Trupanion in the 4th quarter worth about $36,000. Harbor Investment Advisory LLC acquired a new stake in Trupanion in the 3rd quarter worth about $42,000. Finally, Dark Forest Capital Management LP acquired a new stake in Trupanion in the 3rd quarter worth about $66,000. Institutional investors own 83.11% of the company’s stock.
Trupanion Company Profile (Get Rating)
Trupanion, Inc engages in the provision of medical insurance for cats and dogs. It operates through the following segments: Subscription Business and Other Business. The Subscription Business segment is involved in the monthly subscriptions of pet medical insurance. The Others Business segment includes companies or organizations that choose to provide medical insurance for cats and dogs as a benefit to their employees or members.